Pharmacally
Roche
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Roche
Mergers & AcquisitionsHansoh Expands Roche ADC Deal With $15B+ in Potential MilestonesHansoh Pharma and Roche have expanded their ADC collaboration to cover two preclinical Hansoh programs and multiple additional candidates against Roche-proposed targets.Fact-Checked
Mergers & AcquisitionsRoche to Acquire PathAI in Up to $1.05 Billion Digital Pathology DealRoche has agreed to acquire PathAI in a deal that could strengthen its digital pathology and AI-enabled diagnostics portfolio.Fact-Checked
Mergers & AcquisitionsRoche, C4 Therapeutics Launch “Two-in-One” Targeted Cancer StrategyC4 Therapeutics and Roche expand their long-standing partnership to advance degrader-antibody conjugates, combining targeted protein degradation with ADC technology across multiple oncology programs.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.